Generation Investment Management LLP Sells 185,778 Shares of STERIS plc $STE

Generation Investment Management LLP cut its holdings in STERIS plc (NYSE:STE) by 5.9% in the 3rd quarter, HoldingsChannel reports. The fund owned 2,984,939 shares of the medical equipment provider’s stock after selling 185,778 shares during the period. STERIS makes up 4.9% of Generation Investment Management LLP’s investment portfolio, making the stock its 8th largest position. Generation Investment Management LLP’s holdings in STERIS were worth $738,593,000 as of its most recent filing with the SEC.

Other large investors also recently made changes to their positions in the company. Allworth Financial LP boosted its holdings in shares of STERIS by 7.3% during the second quarter. Allworth Financial LP now owns 661 shares of the medical equipment provider’s stock worth $159,000 after purchasing an additional 45 shares during the last quarter. Geneos Wealth Management Inc. lifted its position in STERIS by 34.9% during the second quarter. Geneos Wealth Management Inc. now owns 174 shares of the medical equipment provider’s stock worth $42,000 after buying an additional 45 shares during the period. Fifth Third Bancorp lifted its position in STERIS by 1.6% during the third quarter. Fifth Third Bancorp now owns 2,953 shares of the medical equipment provider’s stock worth $731,000 after buying an additional 46 shares during the period. Tokio Marine Asset Management Co. Ltd. boosted its stake in STERIS by 1.4% in the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 3,494 shares of the medical equipment provider’s stock worth $865,000 after buying an additional 48 shares during the last quarter. Finally, Advisors Capital Management LLC grew its holdings in STERIS by 1.4% in the 3rd quarter. Advisors Capital Management LLC now owns 3,452 shares of the medical equipment provider’s stock valued at $854,000 after buying an additional 48 shares during the period. Hedge funds and other institutional investors own 94.69% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently commented on STE shares. Weiss Ratings reaffirmed a “buy (b)” rating on shares of STERIS in a research note on Friday, January 9th. Wall Street Zen downgraded shares of STERIS from a “strong-buy” rating to a “buy” rating in a report on Saturday, February 14th. Six analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, STERIS presently has a consensus rating of “Moderate Buy” and an average price target of $275.20.

STERIS Trading Down 1.5%

NYSE STE opened at $246.97 on Tuesday. STERIS plc has a one year low of $204.90 and a one year high of $269.44. The company’s 50 day moving average price is $255.96 and its 200 day moving average price is $251.56. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.75 and a current ratio of 2.48. The firm has a market capitalization of $24.22 billion, a price-to-earnings ratio of 34.45 and a beta of 1.03.

STERIS (NYSE:STE) last released its quarterly earnings data on Wednesday, February 4th. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.53. STERIS had a net margin of 12.15% and a return on equity of 14.34%. During the same quarter in the prior year, the company earned $2.32 earnings per share. The company’s revenue was up 9.2% compared to the same quarter last year. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. On average, sell-side analysts predict that STERIS plc will post 9.08 EPS for the current year.

STERIS Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Investors of record on Tuesday, February 17th will be issued a $0.63 dividend. This represents a $2.52 annualized dividend and a yield of 1.0%. The ex-dividend date is Tuesday, February 17th. STERIS’s dividend payout ratio is currently 35.15%.

STERIS Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.